CXCR4 and breast cancer: In agreement with the data reported by Cos and colleagues [3], we have demonstrated that melatonin, at physiological concentrations (10-9 M), significantly inhibits the invasion of MCF-7/6, MCF-7/Her2.1, and MCF-7/CXCR4 breast cancer cells.